Ciclosporin A in bilateral auto-immune chronic posterior uveitis associated with macular oedema: a Long-term Observational Safety and Efficacy Study

Eye ◽  
2021 ◽  
Author(s):  
Munirah Alafaleq ◽  
Romain Freund ◽  
Marie-Aude Penet ◽  
Christine Fardeau ◽  
Corinne Isnard-Bagnis ◽  
...  
Keyword(s):  
Macular Oedema ◽  
Posterior Uveitis ◽  
Efficacy Study ◽  
Safety And Efficacy ◽  
Ciclosporin A

scholarly journals AAV-Mediated Gene Therapy for Galactosialidosis: A Long-term Safety and Efficacy Study

2021 ◽  
Author(s):  
Huimin Hu ◽  
Rosario Mosca ◽  
Elida Gomero ◽  
Diantha van de Vlekkert ◽  
Yvan Campos ◽  
...  
Keyword(s):  
Gene Therapy ◽  
Efficacy Study ◽  
Safety And Efficacy

Multicenter long-term safety and efficacy study of vigabatrin for refractory complex partial seizures: An update

Neurology ◽  
1991 ◽  
Vol 41 (3) ◽  
pp. 363-363 ◽  
Author(s):  
T. R. Browne ◽  
R. H. Mattson ◽  
J. K. Penry ◽  
D. B. Smith ◽  
D. M. Treiman ◽  
...  
Keyword(s):  
Efficacy Study ◽  
Partial Seizures ◽  
Complex Partial Seizures ◽  
Safety And Efficacy

Long-term treatment of hypercholesterolemia with fluvastatin: A 52-week multicenter safety and efficacy study

1994 ◽  
Vol 96 (6) ◽  
pp. S87-S93 ◽  
Author(s):  
Jan Dirk Banga ◽  
Bernard Jacotot ◽  
Pascal Pfister ◽  
Munish Mehra
Keyword(s):  
Term Treatment ◽  
Efficacy Study ◽  
Safety And Efficacy ◽  
Long Term Treatment

Long-term safety and efficacy study of intranasal ipratroprium bromide

1990 ◽  
Vol 104 (2) ◽  
pp. 123-125 ◽  
Author(s):  
C. A. Milford ◽  
T. A. Mugliston ◽  
V. J. Lund ◽  
I. S. Mackay
Keyword(s):  
Side Effects ◽  
Open Trial ◽  
Systemic Effects ◽  
Efficacy Study ◽  
Safety And Efficacy ◽  
Treatment Side Effects ◽  
Main Complaint ◽  
One Year

AbstractForty patients presenting with watery rhinorrhoea as their main complaint were entered in an open trial of long-term intranasal ipratroprium bromide. Fourteen of these (35 per cent) found it to be beneficial and completed one year of treatment. Side-effects were seen in 28 patients (70 per cent) but these were local and mild in nature. All resolved during the trial as patients adjusted the dosage to individual severity and frequency of symptoms. No significant systemic effects were noted during the course of therapy. Ipratroprium is a useful drug in the treatment of watery rhinorroea and appears safe for long-term use.

Sign in / Sign up

Export Citation Format

Share Document